Unilateral adrenal haemorrhage during bridging anticoagulation in primary antiphospholipid syndrome: a case-based review
Clinical Rheumatology · 2026-12 · 45 (12) · 7599-7605
DOI: 10.1007/s10067-026-08471-7 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Rheumatology, online erschienen am 12.10.2026. Verfasst von Neoklis Baris und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, General Hospital of Patras "Agios Andreas", Patras, Greece. mparis.neoklis@gmail.com. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, Hemorrhage, Anticoagulants, Adrenal Gland Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Antiphospholipid syndrome (APS) is a major cause of acquired thrombophilia and is frequently associated with recurrent venous thromboembolism requiring long-term anticoagulation. We report a 42-year-old man with primary APS and recurrent pulmonary embolism and deep vein thrombosis who developed acute right upper-quadrant abdominal pain during peri-procedural bridging anticoagulation with enoxaparin. Computed tomography (CT) and magnetic resonance imaging demonstrated acute-to-subacute unilateral right adrenal haemorrhage without evidence of abdominal trauma, malignancy or infection. The patient remained haemodynamically stable and did not develop adrenal insufficiency. This case highlights the complexity of anticoagulation management in high-risk APS patients and emphasises the importance of considering adrenal haemorrhage in APS patients presenting with abdominal pain during anticoagulation modification. A review of previously reported unilateral APS-associated adrenal haemorrhage cases is also presented. Key Points • Unilateral adrenal haemorrhage is a rare manifestation of primary antiphospholipid syndrome. • Bridging anticoagulation may represent a vulnerable period for adrenal haemorrhage in high-risk APS. • Early CT/MRI imaging and assessment of adrenal function are essential. • Conservative management with careful reintroduction of anticoagulation may lead to favourable outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, General Hospital of Patras "Agios Andreas", Patras, Greece. mparis.neoklis@gmail.com.
- Department of Rheumatology, General Hospital of Patras "Agios Andreas", Patras, Greece.
Zitieren
APA
Baris, N., Chatzistamati, A., Angelopoulos, A., Melissaropoulos, K., Giannopoulos, G., Bounia, K. A., & Vlachanastasi, C. (2026). Unilateral adrenal haemorrhage during bridging anticoagulation in primary antiphospholipid syndrome: a case-based review. Clinical Rheumatology, 45(12), 7599-7605. https://doi.org/10.1007/s10067-026-08471-7
Vancouver
Baris N, Chatzistamati A, Angelopoulos A, Melissaropoulos K, Giannopoulos G, Bounia KA, et al. Unilateral adrenal haemorrhage during bridging anticoagulation in primary antiphospholipid syndrome: a case-based review. Clinical Rheumatology. 2026;45(12):7599-7605. doi:10.1007/s10067-026-08471-7
BibTeX
@article{Baris2026,
author = {Baris, Neoklis and Chatzistamati, Anastasia and Angelopoulos, Andreas and Melissaropoulos, Konstantinos and Giannopoulos, Georgios and Bounia, Konstantina A and Vlachanastasi, Chrisavgi},
title = {Unilateral adrenal haemorrhage during bridging anticoagulation in primary antiphospholipid syndrome: a case-based review},
journal = {Clinical Rheumatology},
year = {2026},
volume = {45},
number = {12},
pages = {7599--7605},
doi = {10.1007/s10067-026-08471-7}
}
EUVIMED